Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10414755 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Patent 10414755 was granted and assigned to Novartis on September, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Novartis

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

104147550

Patent Inventor Names

Aleem Fazal0

Artiom Cernijenko0

Michael Scott Visser0

Ritesh Bhanudasji Tichkule0

Rohan Eric John Beckwith0

Simone Bonazzi0

Date of Patent

September 17, 2019

Patent Application Number

161087130

Date Filed

August 22, 2018

Patent Citations Received

‌

US Patent 12122764 IKAROS zinc finger family degraders and uses thereof

‌

US Patent 10646575 Heterocyclic degronimers for target protein degradation

‌

US Patent 10905768 Heterocyclic degronimers for target protein degradation

‌

US Patent 11787785 Pyrazolopyridine derivatives and uses thereof

‌

US Patent 12076405 Heterocyclic degronimers for target protein degradation

Patent Primary Examiner

‌

Karen Cheng

Patent abstract

The present disclosure provides a compound of Formula (I′):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10414755 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API